Herbalife Ltd (HLF) financial statements: income statement, balance sheet and cash flow
Herbalife Ltd's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Herbalife Ltd reported revenue of $5.0B (+0.9% year on year) and net income of $228.3M (-10.2% year on year).
Income statement
Herbalife Ltd income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$5.0B
$5.0B
$5.1B
$5.2B
Cost of sales
$1.1B
$1.1B
$1.2B
$1.2B
Gross profit
$3.9B
$3.9B
$3.9B
$4.0B
Selling expenses
$1.8B
—
—
—
General and administrative expenses
$1.7B
—
—
—
Other operating income
($4.8M)
($5.5M)
($10.2M)
($14.9M)
Operating income
$481.0M
$385.9M
$356.4M
$545.2M
Interest expense
$214.4M
$218.3M
$165.9M
$139.3M
Interest income
$8.5M
$12.3M
$11.5M
$6.1M
Other expense (income), net
$0
$10.5M
($1.0M)
($12.8M)
Income before income taxes
$275.1M
$169.4M
$203.0M
$424.8M
Income taxes
$47.3M
($84.9M)
$60.8M
$103.5M
Net Income
$227.8M
—
—
—
Net loss attributable to noncontrolling interest
($500.0K)
—
—
—
Net income attributable to Herbalife
$228.3M
$254.3M
$142.2M
$321.3M
Basic
$2.22
$2.53
$1.44
$3.26
Diluted
$2.20
$2.50
$1.42
$3.23
Basic
102.8M
100.6M
99.0M
98.5M
Diluted
103.6M
101.6M
100.2M
99.5M
Herbalife Ltd income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Net sales
$1.3B
$1.3B
$1.3B
$1.3B
Cost of sales
$296.3M
$291.1M
$284.2M
$276.9M
Gross profit
$1.0B
$1.0B
$989.5M
$982.2M
Selling expenses
$466.0M
$461.8M
—
—
General and administrative expenses
$436.2M
$431.4M
—
—
Other operating income
$0
($5.5M)
$0
($4.8M)
Operating income
$128.3M
$138.4M
$125.8M
$132.6M
Interest expense, net
$37.4M
$46.8M
$51.0M
$53.6M
Other expense, net
$94.6M
—
$0
$0
(Loss) Income before income taxes
($3.7M)
$91.6M
$74.8M
$79.0M
Income taxes
$22.8M
$30.4M
$31.7M
$29.8M
Net (loss) income
($26.5M)
$61.2M
$43.1M
$49.2M
Net loss attributable to noncontrolling interest
($200.0K)
($700.0K)
($100.0K)
($100.0K)
Net (loss) income attributable to Herbalife
($26.3M)
$61.9M
$43.2M
$49.3M
Basic
-$0.25
$0.60
$0.42
$0.48
Diluted
-$0.25
$0.57
$0.42
$0.48
Basic
104.5M
103.8M
103.3M
102.7M
Diluted
104.5M
108.4M
104.0M
103.3M
Balance sheet
Herbalife Ltd balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$353.1M
$415.3M
$575.2M
$508.0M
Receivables, net of allowance for doubtful accounts
$91.9M
$68.9M
$81.2M
$70.6M
Inventories
$511.7M
$475.4M
$505.2M
$580.7M
Prepaid expenses and other current assets
$188.0M
$184.1M
$237.7M
$196.8M
Total current assets
$1.1B
$1.1B
$1.4B
$1.4B
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization
$447.7M
$460.2M
$506.5M
$486.3M
Operating lease right-of-use assets
$168.3M
$185.7M
$185.8M
$207.1M
Marketing-related intangibles and other intangible assets, net
$315.1M
$312.3M
$314.0M
$315.7M
Goodwill
$100.5M
$87.7M
$95.4M
$93.2M
Deferred income tax assets
$464.3M
$398.6M
—
—
Other assets
$145.3M
$139.9M
$308.4M
$273.6M
Total assets
$2.8B
$2.7B
$2.8B
$2.7B
Accounts payable
$99.8M
$70.0M
$84.0M
$89.8M
Member compensation liabilities
$402.4M
—
—
—
Current portion of long-term debt
$20.9M
$283.5M
$309.5M
$29.5M
Other current liabilities
$489.8M
$542.8M
$540.7M
$514.0M
Total current liabilities
$1.0B
$1.2B
$1.3B
$976.6M
Long-term debt, net of current portion
$2.0B
$2.0B
$2.3B
$2.7B
Non-current operating lease liabilities
$155.7M
$169.5M
$167.6M
$192.4M
Other non-current liabilities
$155.0M
$152.7M
$171.6M
$166.4M
Total liabilities
$3.3B
$3.5B
$3.9B
$4.0B
Common shares, $0.0005 par value; 2.0 billion shares authorized; 103.3 million (2025) and 101.2 million (2024) shares outstanding
100.0K
100.0K
100.0K
100.0K
Paid-in capital in excess of par value
$316.0M
$278.2M
$233.9M
$188.7M
Accumulated other comprehensive loss
($251.5M)
($271.4M)
($232.0M)
($250.2M)
Accumulated deficit
($579.7M)
($808.0M)
($1.1B)
($1.2B)
Total Herbalife shareholders' deficit
($515.1M)
($801.1M)
($1.1B)
($1.3B)
Noncontrolling interest
$5.7M
—
—
—
Total shareholders' deficit
($509.4M)
—
—
—
Total liabilities and shareholders' deficit
$2.8B
$2.7B
$2.8B
$2.7B
Herbalife Ltd balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$370.5M
$451.2M
$305.5M
$320.9M
Receivables, net of allowance for doubtful accounts
$115.9M
$106.0M
$97.8M
$96.2M
Inventories
$507.7M
$494.6M
$512.5M
$513.1M
Prepaid expenses and other current assets
$174.7M
$200.3M
$190.4M
$172.7M
Total current assets
$1.2B
$1.3B
$1.1B
$1.1B
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization
$412.5M
$429.3M
$456.7M
$465.8M
Operating lease right-of-use assets
$166.7M
$169.0M
$171.7M
$181.8M
Marketing-related intangibles and other intangible assets, net
$333.2M
$314.6M
$315.7M
$316.5M
Goodwill
$125.9M
$99.1M
$101.0M
$101.0M
Deferred income tax assets
$478.6M
$463.7M
$401.7M
$427.8M
Other assets
$172.0M
$147.4M
$144.2M
$140.3M
Total assets
$2.9B
$2.9B
$2.7B
$2.7B
Accounts payable
$101.3M
$88.1M
$88.1M
$91.8M
Member compensation liabilities
$378.0M
$361.1M
—
—
Current portion of long-term debt
$12.0M
$9.2M
$20.7M
$168.0M
Other current liabilities
$482.2M
$563.7M
$545.3M
$505.7M
Total current liabilities
$973.5M
$1.0B
$999.9M
$1.1B
Long-term debt, net of current portion
$2.0B
$2.0B
$2.0B
$2.0B
Non-current operating lease liabilities
$152.1M
$155.2M
$157.0M
$165.4M
Other non-current liabilities
$195.3M
$150.2M
$149.1M
$157.3M
Total liabilities
$3.3B
$3.3B
$3.3B
$3.4B
Common shares, $0.0005 par value; 2.0 billion shares authorized; 104.8 million (2026) and 103.3 million (2025) shares outstanding
100.0K
100.0K
100.0K
100.0K
Paid-in capital in excess of par value
$334.8M
$334.0M
$304.6M
$294.3M
Accumulated other comprehensive loss
($265.3M)
($257.8M)
($251.6M)
($246.6M)
Accumulated deficit
($544.1M)
($517.8M)
($665.1M)
($708.3M)
Total Herbalife shareholders' deficit
($474.5M)
($441.5M)
($612.0M)
($660.5M)
Noncontrolling interest
$7.6M
$7.3M
$6.0M
$6.1M
Total shareholders' deficit
($466.9M)
($434.2M)
($606.0M)
($654.4M)
Total liabilities and shareholders' deficit
$2.9B
$2.9B
$2.7B
$2.7B
Cash flow statement
Herbalife Ltd cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income
$227.8M
$254.3M
$142.2M
$321.3M
Depreciation and amortization
$121.2M
$121.4M
$113.3M
$115.4M
Share-based compensation expenses
$44.1M
$50.0M
$48.0M
$44.4M
Non-cash interest expense
$16.4M
$13.4M
$7.4M
$6.7M
Deferred income taxes
($64.2M)
($229.6M)
($41.1M)
($29.9M)
Inventory write-downs
$25.9M
$18.9M
$28.5M
$38.4M
Foreign exchange transaction loss
$800.0K
$7.6M
$6.0M
$9.1M
Loss (Gain) on extinguishment of debt
$0
$10.5M
($1.0M)
($12.8M)
Other
($3.2M)
$6.4M
$6.5M
($17.0M)
Receivables
($19.7M)
$5.9M
($12.6M)
($9.1M)
Inventories
($27.9M)
($30.4M)
$57.5M
($68.4M)
Prepaid expenses and other current assets
$13.0M
$43.1M
($13.8M)
($12.4M)
Accounts payable
$24.1M
($14.6M)
($7.4M)
($1.1M)
Member compensation liabilities
$23.5M
—
—
—
Other current liabilities
($36.2M)
$40.4M
$23.8M
($53.6M)
Other
($12.3M)
($23.0M)
$6.7M
$31.1M
Net cash provided by operating activities
$333.3M
$285.4M
$357.5M
$352.5M
Purchases of property, plant, and equipment
($80.4M)
($122.0M)
($135.0M)
($156.4M)
Acquisitions of business and assets
($25.5M)
—
—
—
Proceeds from sale and leaseback transaction, net of related expenses
$0
$37.9M
—
—
Other
($2.8M)
($500.0K)
$200.0K
$200.0K
Net cash used in investing activities
($108.7M)
($84.6M)
($134.8M)
($156.2M)
Borrowings from senior secured credit facility and other debt, net of discount
$724.8M
$1.4B
$215.2M
$564.2M
Principal payments on senior secured credit facility and other debt
($746.6M)
($1.9B)
($289.6M)
($683.5M)
Repayment of convertible senior notes
$0
($197.0M)
($64.3M)
($273.2M)
Proceeds from senior secured notes, net of discount
$0
$778.4M
—
—
Repayment of senior notes
($262.3M)
($344.3M)
$0
$0
Debt issuance costs
($100.0K)
($24.0M)
($1.8M)
($7.2M)
Share repurchases
($8.2M)
($8.3M)
($11.0M)
($146.7M)
Other
($3.1M)
$2.5M
$3.2M
$4.2M
Net cash used in financing activities
($295.5M)
($335.3M)
($148.3M)
($264.7M)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
$8.1M
($22.9M)
$4.8M
($25.7M)
Net change in cash, cash equivalents, and restricted cash
($62.8M)
($157.4M)
$79.2M
($94.1M)
Cash, cash equivalents, and restricted cash, beginning of period
$438.1M
$595.5M
$516.3M
$610.4M
Cash, cash equivalents, and restricted cash, end of period
$375.3M
$438.1M
$595.5M
$516.3M
Interest paid
$205.7M
$194.4M
$159.1M
$133.5M
Herbalife Ltd cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income
$34.7M
$61.2M
$142.7M
$99.6M
Depreciation and amortization
$60.8M
$29.4M
$91.9M
$61.2M
Share-based compensation expenses
$20.7M
$10.6M
$33.2M
$22.0M
Non-cash interest expense
$7.0M
$4.2M
$12.3M
$8.2M
Deferred income taxes
($13.9M)
$300.0K
$5.3M
($22.7M)
Inventory write-downs
$12.0M
$5.9M
$21.4M
$14.9M
Foreign exchange transaction loss
$2.1M
($400.0K)
$1.6M
$1.9M
Loss on extinguishment of debt
$94.6M
—
$0
$0
Other
$1.8M
($1.5M)
($1.2M)
($800.0K)
Receivables
($23.7M)
($14.3M)
($25.6M)
($22.4M)
Inventories
($11.8M)
$4.2M
($29.8M)
($21.9M)
Prepaid expenses and other current assets
$17.1M
($6.4M)
$8.9M
$22.5M
Accounts payable
$0
($12.1M)
$12.4M
$16.0M
Member compensation liabilities
($21.6M)
($36.9M)
—
—
Other current liabilities
($15.1M)
$81.3M
($13.8M)
($55.0M)
Other
($18.0M)
($11.7M)
($20.0M)
($5.4M)
Net cash provided by operating activities
$146.7M
$113.8M
$235.0M
$96.2M
Purchases of property, plant, and equipment
($22.2M)
($10.9M)
($61.9M)
($41.1M)
Acquisitions of business and assets
($10.0M)
—
($25.5M)
($25.5M)
Other
($600.0K)
($300.0K)
($2.6M)
($2.8M)
Net cash used in investing activities
($32.8M)
($11.2M)
($90.0M)
($69.4M)
Borrowings from senior secured credit facility and other debt
$603.5M
$67.0M
$552.3M
$270.8M
Principal payments on senior secured credit facility and other debt
($613.9M)
($72.2M)
($543.9M)
($282.1M)
Proceeds from senior secured notes due 2033
$800.0M
—
$0
$0
Repayment of senior secured notes due 2029
($849.0M)
—
—
—
Repayment of senior notes due 2025
$0
$0
($262.3M)
($115.0M)
Debt issuance costs
($19.7M)
—
($100.0K)
($100.0K)
Share repurchases
($10.0M)
($700.0K)
($8.1M)
($6.8M)
Other
$8.4M
$7.9M
($700.0K)
$800.0K
Net cash used in financing activities
($80.7M)
$2.0M
($262.8M)
($132.4M)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
($15.1M)
($6.9M)
$7.7M
$11.1M
Net change in cash, cash equivalents, and restricted cash
$18.1M
$97.7M
($110.1M)
($94.5M)
Cash, cash equivalents, and restricted cash, beginning of period
$375.3M
$375.3M
$438.1M
$438.1M
Cash, cash equivalents, and restricted cash, end of period